news
The new findings suggest that inhibiting p53 can reduce CRISPR-associated…
22 November 2021 | By Anna Begley (Drug Target Review)
The new findings suggest that inhibiting p53 can reduce CRISPR-associated cancer risks and may lead to developments in precision medicine.